The goal of this partnership is to create next-generation treatments, such as antibody-drug conjugates (ADCs) and T cell engagers, using the expertise of both companies. Read full news here:https://www.coherentmarketinsights.com/news/harbour-biomed-partners-with-astrazeneca-on-cancer-treatments-1924 https://www.coherentmarketinsights.com/news/harbour-biomed-partners-with-astrazeneca-on-cancer-treatments-1924